NEU neuren pharmaceuticals limited

Release Today Neuren Valuation Estimate Raised, page-13

  1. 471 Posts.
    lightbulb Created with Sketch.  3
    Yes - the gambling is over - we are now in the calculated risk zone and in a two horse race of success versus failure - success is the favourite, due to all the facts already disclosed - most importantly the fact that there have been no side effects in the trials to date and many positive results (especially with Rhetts) makes success more than likely. Now the business must progress to phase 3 and then production (or failure). My calculation is success, whether it be alone or partnered in some way.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Last
$17.09
Change
-0.420(2.40%)
Mkt cap ! $2.211B
Open High Low Volume
$17.54 $17.56 $16.99 210.4K

Buyers (Bids)

Vol. Price($)
1507 $16.97
 

Sellers (Offers)

Price($) Vol.
$17.12 580
Last trade - 16.25pm 17/07/2026 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.